Patent FR2407720A1 successfully refreshed from Google Patents.
← Back to Patent Explorer
FR2407720A1 Expired / Lapsed FR ⏱️ 0.0 years remaining

Oral sustained-action capsule formulations - of drug and excipient which swells in contact with digestive juices

Assignee: Merck Sante SAS
•
Filing: 1977-11-08
•
Granted: —
•
Expires: 1997-11-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Oral compsns. with sustained activity comprising the active drug and an excipient which swells in contact with digestive juices, this being =45% w/w of the compsn., contained in hard gelatin capsules. The compsns. may contain drugs such as aspirin, nitrofurantoin and naftidrofuryl. Swelling agents include guar gum, tragacanth and hydroxypropylmethylcellulose. A preferred agent with aspirin is 40-45% w/w of hydroxy-propylmethylcellulose; for naftidrofuryl 20-25% w/w of swelling agent. Conventional additives such as lubricants and fillers may be used, e.g. magnesium stearate, lactose kaolin, colloidal silica.

Inventors

  • 👤 Jean-Claude Lechevin
  • 👤 Jean-Noel Treilles
  • 👤 Francoise Merle
  • 👤 Maryse Belleville

Bibliographic Details

Application Number —
Jurisdiction FR
Data Source google_patents
Last Synchronized 2026-11-08 19:03
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/48; A61K9/4841; A61K9/4866

Claims Analysis

Total Claims: 0
No claims parsed yet. Click Sync Now above to re-index claims from Google Patents.

References Cited (Backward Citations)

DE1445105A1 Cited
US3247066A Cited
FR1468716A Cited
US3427378A Cited
US3574820A Cited
LU61171A1 Cited
FR2118492A5 Cited

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag